Abshire v. Livingston Parish

District Court, M.D. Louisiana·Decided February 7, 2025·No. 3:22-cv-00548·Unknown

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF LOUISIANA TAYLOR ABSHIRE, INDIVIDUALLY AND ON BEHALF OF THE UNOPENED SUCCESSION OF RICHARD ABSHIRE, ET AL. CIVIL ACTION VERSUS NO. 22-548-JWD-SDJ LIVINGSTON PARISH, ET AL. RULING AND ORDER This matter comes before the Court on the Motion for Summary Judgment (Doc. 57) filed by Defendant Dr. James Taylor (“Dr. Taylor”). Plaintiffs Taylor Abshire, Kaysi Abshire, and Lindsey Johnson, all individually and on behalf of the unopened succession of Richard Abshire, and Lindsey Johnson as next of friend of E.A. and A.A. (collectively, “Plaintiffs”) oppose the motion (Doc. 66). Dr. Taylor has filed a reply (Doc. 75). Oral argument is not necessary. The Court has carefully considered the law, the facts in the record, and the arguments and submissions of the parties and is prepared to rule. For the following reasons, the Motion for Summary Judgment is granted. I. RELEVANT FACTUAL BACKGROUND1 Richard Abshire became Dr. Christopher Trevino’s patient at Tulane Medical Center in October 2019 to treat his newly diagnosed glioblastoma brain cancer. (PSUMF, Doc. 66-1 at 9, ¶ 1.) Glioblastoma is an aggressive form of brain cancer associated with a very short lifespan if the

1 Unless otherwise indicated, when the Court cites to Plaintiff’s Statement of Undisputed Material Facts (“PSUMF”) or Taylor’s Statement of Material Facts (“TSMF”) in support of a fact, that fact has been admitted by the opposing party. See M.D. La. Civ. R. 56(f) patient is untreated. (Id. at 10, ¶ 2.) Dr. Trevino performed surgery on Mr. Abshire and ordered chemotherapy and an Optune to be worn 18 hours a day. (Id. at ¶ 3.) The Optune is an FDA approved device, made by Novocure, designed to deliver continuous therapy for glioblastoma patients, which can result in a five-year survival rate increase from 5%

to 13% when worn for the recommended amount of time. (Id. at ¶ 4; Response to Plaintiffs’ Statement of Undisputed Material Facts (RPSUMF), Doc. 75-1 at 1, ¶ 4.) Mr. Abshire used his Optune for the 15 months prior to his incarceration, with usage above 75% for the first two months and below 75% the remaining months. (TSMF, Doc. 57-2 at 9, ¶ 57; RPSUMF, Doc. 75-1 at 1, ¶ 4.) Dr. Trevino planned to monitor Mr. Abshire through surveillance MRIs. (PSUMF, Doc. 66-1 at 10, ¶ 7.) Mr. Abshire was incarcerated at the Livingston Parish Detention Center (“LPDC”) on July 11, 2021. (Id. at 11, ¶ 11.) The next day, he told medical staff at the LPDC that he had been diagnosed with brain cancer, and LPDC staff requested his medical records from Tulane Oncology. (Id. at ¶ 13.) While Mr. Abshire was a pre-trial detainee, Dr. James Taylor, the Medical Director

at LPDC, was physically within the LPDC two days a week. (TSMF, Doc. 57-2 at 2, ¶¶ 3–4.) After first seeing Mr. Abshire on July 15, 2021, Dr. Taylor told him that any medical treatment or testing would be performed at University Medical Center, New Orleans. (Id. at 3–4, ¶¶ 15–16.) Dr. Taylor continued the medications that Mr. Abshire had previously been on and increased his prescription for Buspar to 10 milligrams three times a day for three months. (Id. at 4, ¶ 17.) Dr. Taylor noted that if Mr. Abshire’s neurological status declined, he would need an MRI. (Id. at ¶ 20.) LPDC received Mr. Abshire’s records from Tulane on July 19, 2021. (PSUMF, Doc. 66-1 at 11, ¶ 14.) Dr. Taylor spoke with Dr. Trevino about Mr. Abshire, his need for the Optune, the recommended 18 hours a day usage, and Mr. Abshire’s MRI appointment. (Id. at 12, ¶¶ 21–22; TSMF, Doc. 57-2 at 4, ¶¶ 21–22.) Soon after this conversation, Dr. Taylor indicated to Nursing Supervisor Courtney Chaney that they needed to “see about getting [Mr. Abshire’s] device.” (TSMF, Doc, 57-2 at 4, ¶ 23; Dr. Taylor Dep., Doc. 47-10 at 79:4–9.) During Mr. Abshire’s incarceration, Taylor Abshire—Mr. Abshire’s daughter and a

plaintiff in this case—attempted to get Mr. Abshire’s Optune from his home, but the device was damaged by Mr. Abshire’s fiancé throwing it down the stairs. (PSUMF, Doc. 66-1 at 11, ¶ 15.) The family was concerned that the Optune was broken, and a piece was missing, so a new device was ordered. (Id. at ¶ 16.) The new Optune was delivered to the LPDC on July 30, 2021. (Id. at 12, ¶ 17.) The new Optune was placed in Ms. Chaney’s office that day but was not opened until August 12, 2021. (Id. at 14, ¶¶ 30–31.)2 On August 2, 2021, Dr. Taylor referred Mr. Abshire to hematology/oncology through the Livingston Parish Detention Center Doctor Call. (TSMF, Doc. 57-2 at 5, ¶ 28.) The same day, LPDC contacted the Department of Corrections (“DOC”) and requested an oncology appointment with imaging, which was scheduled for August 31, 2021. (Id. at ¶ 29.) The appointment was

cancelled because of Hurricane Ida. (Id.) On August 24, 2021, Dr. Taylor visited Mr. Abshire, had his vitals taken, and obtained a history from him. (Id. at 7, ¶ 40.) At this visit, Mr. Abshire reported an increase in headaches and trouble sleeping. (Id. at ¶ 40.) On September 9, 2021, Dr. Taylor saw Mr. Abshire in response to his complaints of confusion, and “advised that his referral for Hematology/Oncology was back in the system.” (Id. at ¶ 44.) Two days later, Mr. Abshire passed out and was transferred to Our Lady

2 The Court notes that PSUMF states the date as August 12, 2022, but given that Plaintiffs admit to TSMF ¶ 30, stating the date as August 12, 2021, and that Mr. Abshire passed away in November 2021, the discrepancy seems to be a mere typographical error. of the Lake, which Dr. Taylor did not need to approve because Mr. Abshire’s situation was emergent. (Id. at ¶¶ 46–47.) Mr. Abshire was released on his own recognizance and went for treatment by Dr. Trevino at Tulane Medical Center. (PSUMF, Doc. 66-1 at 23, ¶ 97; TSMF, Doc. 57-2 at 8, ¶ 52.) An MRI

revealed that a tumor had developed in the back left part of Mr. Abshire’s brain, away from his original tumor site, which was on the front right. (TSMF, Doc. 57-2 at 8, ¶¶ 49–52.) Dr. Trevino performed surgery to address the tumor, but Mr. Abshire passed away on November 28, 2021, due to complications from the surgery. (Id. at ¶ 54.) II. RULE 56 STANDARD “The court shall grant summary judgment if the movant shows that there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). “The movant bears the initial burden and must identify ‘those portions of the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, which it believes demonstrate the absence of a genuine issue of material fact.’ ”

Pioneer Expl., L.L.C. v. Steadfast Ins. Co., 767 F.3d 503, 511 (5th Cir. 2014) (quoting Celotex Corp. v. Catrett, 477 U.S. 317, 323 (1986) (internal quotation marks omitted)). However, “the movant ‘need not negate the elements of the nonmovant’s case.’ ” Id. (quoting Boudreaux v. Swift Transp. Co., 402 F.3d 536, 540 (5th Cir. 2005) (quoting Little v. Liquid Air Corp., 37 F.3d 1069, 1075 (5th Cir. 1994) (en banc))). That is, “[a] movant for summary judgment need not set forth evidence when the nonmovant bears the burden of persuasion at trial.” Wease v. Ocwen Loan Servicing, L.L.C., 915 F.3d 987, 997 (5th Cir. 2019) (citing Celotex, 477 U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Abshire v. Livingston Parish, (M.D. La. 2025).

Abshire v. Livingston Parish (Abshire v. Livingston Parish) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Little v. Liquid Air Corp.
37 F.3d 1069 (Fifth Circuit, 1994)
Banuelos v. McFarland
41 F.3d 232 (Fifth Circuit, 1995)
Hare v. City of Corinth, Miss.
74 F.3d 633 (Fifth Circuit, 1996)
Domino v. Texas Department of Criminal Justice
239 F.3d 752 (Fifth Circuit, 2001)
Gibbs v. Grimmette
254 F.3d 545 (Fifth Circuit, 2001)
Stahl v. Novartis Pharmaceuticals Corp.
283 F.3d 254 (Fifth Circuit, 2002)
Boudreaux v. Swift Transportation Co.
402 F.3d 536 (Fifth Circuit, 2005)
Gobert v. Caldwell
463 F.3d 339 (Fifth Circuit, 2006)
Easter v. Powell
467 F.3d 459 (Fifth Circuit, 2006)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Creighton
483 U.S. 635 (Supreme Court, 1987)
West v. Atkins
487 U.S. 42 (Supreme Court, 1988)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Pioneer Exploration, L.L.C. v. Steadfast Insurance
767 F.3d 503 (Fifth Circuit, 2014)
Thad Delaughter v. Ronald Woodall
909 F.3d 130 (Fifth Circuit, 2018)
Michael Wease v. Ocwen Loan Servicing, L.L.C., et
915 F.3d 987 (Fifth Circuit, 2019)